Literature DB >> 22715058

Self-induced accumulation of glutamate in striatal astrocytes and basal ganglia excitotoxicity.

Ingrid Morales1, Manuel Rodriguez.   

Abstract

Excitotoxicity induced by high levels of extracellular glutamate (GLU) has been proposed as a cause of cell degeneration in basal ganglia disorders. This phenomenon is normally prevented by the astrocytic GLU-uptake and the GLU-catabolization to less dangerous molecules. However, high-GLU can induce reactive gliosis which could change the neuroprotective role of astrocytes. The striatal astrocyte response to high GLU was studied here in an in vivo rat preparation. The transient striatal perfusion of GLU (1 h) by reverse microdialysis induced complex reactive gliosis which persisted for weeks and which was different for radial-like glia, protoplasmic astrocytes and fibrous astrocytes. This gliosis was accompanied by a persistent cytosolic accumulation of GLU (immunofluorescence quantified by confocal microscope), which persisted for weeks (self-induced glutamate accumulation), and which was associated to a selective decrease of glutamine synthetase activity. This massive and persistent self-induced glutamate accumulation in striatal astrocytes could be an additional factor for the GLU-induced excitotoxicity, which has been implicated in the progression of different basal ganglia disorders.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22715058     DOI: 10.1002/glia.22368

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  13 in total

Review 1.  A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease.

Authors:  Giulia Ambrosi; Silvia Cerri; Fabio Blandini
Journal:  J Neural Transm (Vienna)       Date:  2014-01-01       Impact factor: 3.575

Review 2.  Glia-immune interactions post-ischemic stroke and potential therapies.

Authors:  Jessica Hersh; Shao-Hua Yang
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-11

Review 3.  Mechanisms of Excessive Extracellular Glutamate Accumulation in Temporal Lobe Epilepsy.

Authors:  Jan Albrecht; Magdalena Zielińska
Journal:  Neurochem Res       Date:  2016-11-21       Impact factor: 3.996

4.  Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes.

Authors:  Matthew Neal; Jie Luo; Dilshan S Harischandra; Richard Gordon; Souvarish Sarkar; Huajun Jin; Vellareddy Anantharam; Laurent Désaubry; Anumantha Kanthasamy; Arthi Kanthasamy
Journal:  Glia       Date:  2018-09-12       Impact factor: 7.452

5.  Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.

Authors:  İbrahim Halil Yelkenli; Emel Ulupinar; Orhan Tansel Korkmaz; Erol Şener; Gökhan Kuş; Zeynep Filiz; Neşe Tunçel
Journal:  J Mol Neurosci       Date:  2016-04-26       Impact factor: 3.444

Review 6.  Parkinson's disease as a result of aging.

Authors:  Manuel Rodriguez; Clara Rodriguez-Sabate; Ingrid Morales; Alberto Sanchez; Magdalena Sabate
Journal:  Aging Cell       Date:  2015-02-09       Impact factor: 9.304

Review 7.  Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents.

Authors:  Ian A Clark; Bryce Vissel
Journal:  J Neuroinflammation       Date:  2016-09-05       Impact factor: 8.322

8.  Immature spinal cord neurons are dynamic regulators of adult nociceptive sensitivity.

Authors:  Gabriel Rusanescu; Jianren Mao
Journal:  J Cell Mol Med       Date:  2015-07-30       Impact factor: 5.310

9.  Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model.

Authors:  Ingrid Morales; Alberto Sanchez; Clara Rodriguez-Sabate; Manuel Rodriguez
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

10.  Increased expression of the P2X7 receptor in temporal lobe epilepsy: Animal models and clinical evidence.

Authors:  Penghui Song; Jing Hu; Xijin Liu; Xuejun Deng
Journal:  Mol Med Rep       Date:  2019-04-30       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.